Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ENGN
#2490
enGene Holdings Inc. Common Stock
10.110
0
+0.20%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.20%
Monthly Change
-9.25%
6 month change
+20.36%
Year Change
+20.36%
Previous Close
10.090
0
Open
10.110
0
Bid
Ask
Low
10.110
0
High
10.110
0
Volume
9
Markets
US Stock Market
Healthcare
ENGN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.2 M
50.98 M
66.98 M
—
Valuation ratios
Enterprise value
382.44 M
278.14 M
432.76 M
1.03 B
Price to earnings ratio
0.13
6.06
3.15
12.28
Price to sales ratio
3.87
848.66
122.86 K
146.96 K
Price to cash flow ratio
0.56
6.92
3.72
12.51
Price to book ratio
0.19
1.23
2.2
2.86
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
1.15
0.18
0.53
0.47
Return on equity %
1.38
0.2
0.7
0.58
Return on invested capital %
3 669.8
660.95
879.54
892.76
Gross margin %
100
100
100
400
Operating margin %
727.93
15.81 K
4.11 M
265.26 K
EBITDA margin %
—
—
—
—
Net margin %
2 790.98
14 K
3.91 M
257.65 K
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
16.25
16.87
6.3
46.46
Inventory turnover
—
—
—
—
Asset turnover
0.04
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
0.11
0.07
0.07
0.29
Long term debt to total equity ratio
0.13
0.08
0.09
0.35
Per share metrics
Operating cash flow per share
35.66
1.28
1.94
1.94
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
117.7
6.31
3.79
16.2
Net current asset value per share
123.36
6.55
3.94
16.91
Tangible book value per share
104.66
7.22
3.28
16.57
Working capital per share
115.77
6.16
3.31
15.28
Book value per share
104.66
7.22
3.28
16.57
News
Top SMID Cap Biotech Stocks to Watch According to Morgan Stanley
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Jefferies initiates coverage on Engene stock with Buy rating
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN)
Citizens reiterates Market Outperform rating on Engene stock with $21 target
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages
CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)
enGene completes enrollment in bladder cancer treatment trial
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program
enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program
FDA selects enGene’s bladder cancer therapy for development program